KÄÄPÄ Biotech
KÄÄPÄ Biotech is a Finnish biotech company that produces and supplies functional mushroom extract ingredients (lion's mane, chaga, cordyceps, reishi) on a B2B basis to nutraceutical manufacturers and functional food producers globally, using vertically integrated cultivation and extraction operations.
- Company typePrivate
- Founded2016
- HeadquartersKarjalohja, Finland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What KÄÄPÄ Biotech does
KÄÄPÄ Biotech is a privately held Finnish biotechnology company, founded in 2016 and headquartered in Karjalohja, Finland, that researches, develops, and supplies functional mushroom ingredients — specifically lion's mane, chaga, cordyceps, and reishi extracts — to the global nutraceutical and functional-food industries on a B2B basis. The company operates a vertically integrated production model spanning mushroom cultivation through proprietary extraction processes, with the explicit aim of controlling quality and consistency across the supply chain while supporting clinical research on the longevity and health benefits of its ingredients.
The company sells standardized functional mushroom extracts to nutraceutical manufacturers, dietary supplement brands, and functional food producers, using a quote-based B2B direct-sales model in which pricing is not publicly disclosed and contracts are negotiated per customer. Customer segmentation is concentrated on a single horizontal segment — nutraceutical/functional-food manufacturers — and there are no publicly disclosed customer logos, ARR figures, or revenue disclosures. The product surface is a focused four-ingredient portfolio rather than a broad SKU catalogue.
In November 2025, KÄÄPÄ Biotech closed a €9 million strategic investment co-led by PeakBridge and Zintinus, earmarked for increasing production capacity, improving extraction processes, expanding operations, and strengthening market position in the global functional mushroom ingredients market. The company states its ambition to set quality standards in the mushroom-based health product category, positioning itself as a supply-chain-controlled ingredient supplier rather than a finished consumer-goods brand.
KÄÄPÄ Biotech firmographics
Firmographics- Name
- KÄÄPÄ Biotech
- Legal name
- KÄÄPÄ Biotech
- Website
- https://kaapabiotech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- KÄÄPÄ Biotech is a Finnish biotech company that produces and supplies functional mushroom extract ingredients (lion's mane, chaga, cordyceps, reishi) on a B2B basis to nutraceutical manufacturers and functional food producers globally, using vertically integrated cultivation and extraction operations.
- Ownership category
- akta.pro rank
KÄÄPÄ Biotech industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411), Spice and Extract Manufacturing (311942)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
- akta.pro secondary industry
- Mushroom & Fungi Production (Indoor/Protected) (AFAGAHAK)
Keywords
Where KÄÄPÄ Biotech is headquartered
LocationHeadquarters
- HQ city
- Karjalohja
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
KÄÄPÄ Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Functional Mushroom Ingredients B2B Sales: Sale of functional mushroom ingredients (lion's mane, chaga, cordyceps, reishi) to nutraceutical manufacturers and brands in the global market. Revenue generated through bulk ingredient supply to B2B customers in the health product sector.
Distribution channels1 record
KÄÄPÄ Biotech product offering
Product offeringCore offering
KÄÄPÄ Biotech produces and supplies functional mushroom ingredient extracts — including lion's mane, chaga, cordyceps, and reishi — through vertically integrated cultivation and proprietary extraction processes. The company sells these standardized mushroom extracts on a B2B basis to nutraceutical manufacturers, dietary supplement brands, and functional food producers in the global market.
Product overview
KÄÄPÄ Biotech is a Finnish biotech company operating in the functional mushroom ingredients sector, supplying B2B ingredients (lion's mane, chaga, cordyceps, and reishi extracts) to the global nutraceutical and health product markets. The company focuses on vertical integration, improved extraction processes, and clinical research on longevity benefits. Funded by a €9 million strategic investment from PeakBridge and Zintinus in November 2025 to expand production capacity and market position.
Differentiator
Problem solved
Functional benefit
Products and services
- Functional Mushroom Ingredients KÄÄPÄ Biotech's overarching offering: functional mushroom ingredient extracts (lion's mane, chaga, cordyceps, reishi) supplied to nutraceutical and health product manufacturers on a B2B basis. Produced through vertically integrated cultivation and proprietary extraction processes.
- Lion's Mane Extract Functional mushroom ingredient extract derived from lion's mane, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
- Chaga Extract Functional mushroom ingredient extract derived from chaga, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
- Cordyceps Extract Functional mushroom ingredient extract derived from cordyceps, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
- Reishi Extract Functional mushroom ingredient extract derived from reishi, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
Companies that use KÄÄPÄ Biotech
Customer profileSegments1 record
Ideal customer profiles1 record
KÄÄPÄ Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
KÄÄPÄ Biotech partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
KÄÄPÄ Biotech competitors and assessment
Company assessmentDirect peers
- Nammex: Nammex is a North American supplier of organic mushroom extracts for the supplement industry, offering fruiting-body extracts of reishi, lion's mane, cordyceps, and chaga. It is the closest direct competitor to KÄÄPÄ in B2B functional mushroom ingredients, with comparable product breadth, B2B model, and premium quality positioning.
- M2 Ingredients: M2 Ingredients supplies organic, whole-food mushroom powders and extracts for functional food and supplement brands. It is a direct peer to KÄÄPÄ, serving the same B2B nutraceutical customers with similar functional mushroom species and a comparable emphasis on quality and traceability.
- Real Mushroom: Real Mushroom supplies 100% mushroom-fruiting-body extracts to supplement and functional food manufacturers globally. It directly competes with KÄÄPÄ in the premium B2B extract category, with overlapping species portfolio and a similar quality-differentiation narrative.
- Hifas da Terra: Hifas da Terra is a Spanish biotech company that develops and produces functional mushroom extracts for nutraceutical and clinical applications. Comparable to KÄÄPÄ in vertical integration, European base, and B2B focus on therapeutic-grade mushroom ingredients.
Emerging players
- MycoTechnology: MycoTechnology is a US-based fermentation and mycelium-ingredient company developing protein and functional ingredients using fungal platforms. Adjacent to KÄÄPÄ in biotechnology approach and B2B ingredient supply, though focused more on food protein than nutraceutical extracts.
Regional players
- Life Cykel: Life Cykel is an Australian functional mushroom company producing extracts and ingredients from upcycled coffee waste substrates. It is comparable to KÄÄPÄ in functional mushroom extracts and B2B nutraceutical supply, though primarily serving the Australian and APAC markets.
Broad incumbents
- Four Sigmatic: Four Sigmatic is a global functional mushroom brand selling mushroom coffee, elixirs, and supplements direct-to-consumer. It operates in the same functional mushroom category as KÄÄPÄ but is downstream (B2C brand) rather than upstream B2B ingredient supplier, making it an adjacent incumbent rather than direct competitor.
- Fungi Perfecti (Host Defense): Fungi Perfecti, founded by Paul Stamets, produces and sells Host Defense mushroom supplements and related functional mushroom products. Comparable to KÄÄPÄ in the functional mushroom category and cultivation expertise, but focused on finished B2C supplement products rather than B2B ingredient supply.
- Layn Natural Ingredients: Layn Natural Ingredients is a global supplier of botanical extracts, including functional mushroom extracts, to food, beverage, and nutraceutical manufacturers. It overlaps with KÄÄPÄ in plant-based extract manufacturing and B2B nutraceutical supply but operates across a much broader botanical portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks3 records
Key highlights1 record
Customer concentration
KÄÄPÄ Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
KÄÄPÄ Biotech leadership team
Management profileNumber of profiles
Profiles3 records
KÄÄPÄ Biotech funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KÄÄPÄ Biotech M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KÄÄPÄ Biotech
What does KÄÄPÄ Biotech do?
KÄÄPÄ Biotech produces and supplies functional mushroom ingredient extracts — including lion's mane, chaga, cordyceps, and reishi — through vertically integrated cultivation and proprietary extraction processes. The company sells these standardized mushroom extracts on a B2B basis to nutraceutical manufacturers, dietary supplement brands, and functional food producers in the global market.
Is KÄÄPÄ Biotech a public or private company?
KÄÄPÄ Biotech is a private company. It is classified as venture growth investor backed and is currently operating.
When was KÄÄPÄ Biotech founded?
KÄÄPÄ Biotech was founded in 2016. It employs 11 to 50 people.
Where is KÄÄPÄ Biotech based?
KÄÄPÄ Biotech is headquartered in Karjalohja, Finland, in the Europe region.
How does KÄÄPÄ Biotech make money?
One revenue line is on record: functional Mushroom Ingredients B2B Sales.
Who are KÄÄPÄ Biotech's main competitors?
Direct peers on record are Nammex, M2 Ingredients, Real Mushroom and Hifas da Terra. MycoTechnology is listed as an emerging player. Life Cykel is listed as a regional player. Broad incumbents are Four Sigmatic, Fungi Perfecti (Host Defense) and Layn Natural Ingredients.
Does KÄÄPÄ Biotech have an API?
No public API is recorded for KÄÄPÄ Biotech.
What industry is KÄÄPÄ Biotech in?
KÄÄPÄ Biotech's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of AFAGAHAK, Mushroom & Fungi Production (Indoor/Protected). Its NAICS code is 325411 and its SIC code is 2833.